SIGA Technologies – executive interview

SIGA Technologies – executive interview

SIGA Technologies — 4 videos in collection

More on this equity

SIGA Technologies is a commercial-stage health security company focused on the treatment of smallpox and other orthopoxviruses. It has contracts with both the US and Canadian governments for TPOXX, its treatment for smallpox, and is looking to expand internationally. As the leading smallpox therapeutic manufacturer, SIGA is likely to remain a beneficiary through the monkeypox epidemic.

In this video, CEO Phillip L Gomez, PhD, provides an update on recent events and SIGA’s strategy.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free